Heterogeneous catalysis to drive the waste-to-pharma concept: From furanics to active pharmaceutical ingredients

A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key molecule examples: Ancarolol and Furosemide. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Authors
Luque R. 1, 2 , Alothman Z.A. 2 , Balu A.M. 1 , Voskressensky L. 3
Journal
Molecules
Publisher
MDPI AG
Issue number
21
Language
English
State
Published
Link
External link
DOI
10.3390/MOLECULES26216738
Number
6738
Volume
26
Year
2021
Organizations
  • 1 Departamento de Química Orgánica, Campus de Rabanales, Universidad de Córdoba, Edificio Marie Curie (C-3), Ctra Nnal IV-A, Km 396, Cordoba, 14014, Spain
  • 2 Chemistry Department, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia
  • 3 Department of Chemistry, Peoples Friendship University of Russia (RUDN University), 6 Miklukho Maklaya St., Moscow, 117198, Russian Federation
Keywords
APIs; Furanics; Heterogeneous catalysis; Waste-to-pharma
Cite
ГОСТ MLA RIS BibTex
Share

Other records